Mechanical Thrombolysis in Ischemic Stroke Attributable to Basilar Artery Occlusion as First-Line Treatment
Stroke 37:145-150, Bergui,M.,et al, 2006
Urgent Clinical Challenges in Children With Ischemic Stroke
Stroke 37:116-122,3, Kuhle,S.,et al, 2006
Thrombolysis in Stroke Patients Aged 80 Years and Older: Swiss Survey of IV Thrombolysis
Neurol 65:1795-1798,1690, Engelter,S.T.,et al, 2005
Is Hospitalization After TIA Cost-Effective on the Basis of Treatment With tPA?
Neurol 65:1799-1801, Nguyen-Huynh,M.N. &Johnson,S.C., 2005
Clinical and Imaging Predictors of Intracerebral Haemorrhage in Stroke Patients Treated with Intravenous Tissue Plasminogen Activator
JNNP 76:70-75, Derex,I.,et al, 2005
Vertebrobasilar Disease
NEJM 352:2618-2626, Savitz,S.I.&Caplan,L.R., 2005
Time to Hospital Arrival, Use of Thrombolytics, and In-Hospital Outcomes in Ischemic Stroke
Neurol 64:2115-2120, Qureshi,A.I.,et al, 2005
Transcranial Low-Frequency Ultrasound-Mediated Thrombolysis in Brain Ischemia
Stroke 36:1441-1446, Daffertshofer,M.,et al, 2005
Houston Paramedic and Emergency Stroke Treatment and Outcomes Study (HoPSTO)
Stroke 36:1512-1518, Wojner-Alexandrov,A.,et al, 2005
Predictors of Early Arterial Reocclusion After Tissue Plasminogen Activator-Induced Recanalization in Acute Ischemic Stroke
Stroke 36:1452-1456, Rubiera,M.,et al, 2005
Safety and Efficacy of Mechanical Embolectomy in Acute Ischemic Stroke, Results of the MERCI Trial
Stroke 36:1432-1440, Smikth,W.D.,et al, 2005
Intravenous rt-PA for Acute Stroke: Comparing Its Effectiveness in Younger and Older Patients
JNNP 76:1234-1237, Mouradian,M.S.,et al, 2005
MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe
Stroke 36:1939-1943, Kang,D.-W.,et al, 2005
REACH Clinical Feasibility of a Rural Telestroke Network
Stroke 36:2018-2020, Hess,D.C.,et al, 2005
Use of Mechanical Extraction Devices in Basilar Artery Occlusion
JNNP 76:1462-1464, Favrole,P.,et al, 2005
Agressive Therapy With Intravenous Abciximab and Intra-Arterial rtPA and Additional PTA/Stenting Improves Clinical Outcome in Acute Vertebrobasilar Occlusion
Stroke 36:1160-1165, Eckert,B.,et al, 2005
Perfusion Computed Tomography: Prediction of Final Infarct Extent and Stroke Outcome
Ann Neurol 58:672-679,661, Parsons,M.W.,et al, 2005
Economic Benefit of Increasing Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in the United States
Stroke 36:2500-2503, Demaerschalk,B.M. &Yip,T.R., 2005
Poor Outcomes in Patients Who Do Not Receive Intravenous Tissue Plasminogen Activator Because of Mild or Improving Ischemic Stroke
Stroke 36:2497-2499, Smith,E.E.,et al, 2005
Outcome and Severe Hemorrhagic Complications of Intravenous Thrombolysis With Tissue Plasminogen Activator in Very Old (=80 Years) Stroke Patients
Stroke 36:2421-2425, Berrouschot,J.,et al, 2005
Reversal of Dense Signs Predicts Recovery in Acute Ischemic Stroke
Stroke 36:e2490-e2492, Mandava,P. &Kent,T.A., 2005
Clinical Importance of Microbleeds in Patients Receiving IV Thrombolysis
Neurol 65:1175-1178, Kakuda,W.,et al, 2005
Endovascular Recanalization of Internal Carotid Artery Occlusion in Acute Ischemic Stroke
AJNR 26:2591-2594, Sugg,R.M.,et al, 2005
tPA By Telephone: Extending the Benefits of a Comprehensive Stroke Center
Neurol 64:154-156, Frey,J.L.,et al, 2005
Telemedicine for Safe and Extended Use of Thrombolysis in Stroke
Stroke 36:287-291, Audebert, H.J., et al, 2005
Aggressive Mechanical Clot Disruption
Stroke 36:292-296, Noser, E.A., et al, 2005
Magnetic Resonance Imaging Criteria for Thrombolysis in Acute Cerebral Infarct
Stroke 36:388-397, Hjort, N., et al, 2005
Approval of the MERCI Clot Retriever-A Critical View
Stroke 36:400-403, Becker, K.J.., & Brott, T.G., 2005
Combined IV and intra-arterial thrombolysis for acute ischemic stroke
Neurol 64:386-388, Flaherty, M.L., et al, 2005
Do the Brain Attack Coalition's Criteria for Stroke Centers Improve Care for Ischemic Stroke?
Neurol 64:422-427, Douglas, V.C., et al, 2005
Intraocular Haemorrhage after Thrombolysis
Lancet 365:330, Kaba, R.A., et al, 2005
Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection Protocol
Stroke 36:602-606, Ribo,M., et al, 2005
Prioritizing interventions to Improve Rates of Thrombolysis for Ischemic Stroke
Neurol 64:654-659, California Acute Stroke Pilot Registry (CASPR) Inv, 2005
Reasons for Exclusion From Thrombolytic Therapy Following Acute Ischemic Stroke
Neurol 64:719-720, Cocho,D., et al, 2005
Spinal Cord Transient Ischemic Attacks: A Possible Role for Abciximab
Neurol 64: 761-762, Hussain, M.S., et al, 2005
Sonothrombolysis in Acute Ischemic Stroke for Patients Ineligible for rt-PA
Neurol 64:1052-1054, Eggers,J., et al, 2005
Prospective Reliability of the Stroke Doc Wireless/Site Independent Telemedicine System
Neurol 64:1058-1060, Meyer,B.C., et al, 2005
Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 36:916-921, Adams,H.,et al, 2005
Reversal of Warfarin-Induced Anticoagulation with Factor VIIa Prior to rt-PA in Acute Stroke
Neurol 64:1480-1481, Talkad,A.,et al, 2005
Thrombolytic Therapy of Acute Ischemic Stroke: Correlation of Angiographic Recanalization with Clinical Outcome
AJNR 26:880-884, Zaidat,O.O.,et al, 2005
Mechanical Thrombectomy for Acute Stroke
AJNR 26:875-879, Versnick,E.J.,et al, 2005
Thrombosis of the Cerebral VEins and Sinuses
NEJM 352:1791-1798, Stam,J., 2005
Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1099-1100, 1100, Zivin,J.A., 2005
Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now Be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1098-1099,1100, Schellinger,P.D. &Fiebach,J.B., 2005
IV Thrombolysis in Patients with Acute Stroke Due to Spontaneous Carotid Dissection
Neurol 64:1612-1614, Georgiadis,D.,et al, 2005
Utility of an Ultrafast Magnetic Resonance Imaging Protocol in Recent and Semi-Recent Strokes
JNNP 76:1002-1005,905, U-King-Im,J.M.,et al, 2005
The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase
Stroke 36:66-73, Hacke,W.,et al, 2005
Posterior Cerebral Artery Stroke
e medicine, Hill,M.D., 2005
Hypoattenuation on CT Angiographic Source Images Predicts Risk of Intracerebral Hemorrhage and Outcome After Intra-Arterial Reperfusion Therapy
AJNR 26:1798-1803, Schwamm,L.,et al, 2005
Multiple Cerebral Microbleeds:MRI Marker of a Diffuse Hemorrhage-Prone State
J Neuroimaging 14:54-57, Chalela,J.A.,et al, 2004